Medication info
Simvast Tablets 20 mg (Simvastatin)

Simvast Tablets 20 mg (Simvastatin)

Prescription medicationTabletOral
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
Yellowish brown oval film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 200202205 · Notified 2002.07.20 · Insurance code 643501460

Summary

Main use
Improvement of hyperlipidemia and pediatric familial hypercholesterolemia; prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medication. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medication once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medication. A dose of 5 ~ 40 mg of this medication once daily in the evening is recommended. Adjust the dose appropriately according to the initial LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the medication. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if cholesterol levels fall below the target level. Due to the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this medication, particularly during the first year of treatment, should be limited to patients who have taken 80 mg of this medication for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) See below for recommended doses in patients taking this medication concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on results from controlled clinical trials, patients with homozygous familial hypercholesterolemia should take 40 mg of this medication once daily in the evening. Administer this medication in combination with other lipid-lowering treatments (e.g., LDL apheresis), or if other lipid-lowering treatments are not available. (2) In elderly patients, the maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this medication. (3) Use in patients taking verapamil, diltiazem, or dronedarone When this medication is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medication should not exceed 10 mg daily. (4) Use in patients taking amiodarone, amlodipine, or ranolazine When this medication is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medication should not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering agents This medication is effective when used alone or in combination with a bile acid sequestrant. When this medication is coadministered with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medication should not exceed 10 mg daily. (6) Use in patients with renal impairment Because this medication is not extensively excreted by the kidneys, no dose adjustment is needed in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg daily and monitor carefully.
Child dose
10 ~ 17 years: The recommended initial dose is 10 mg of this medication once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia and pediatric familial hypercholesterolemia; prevention of cardiovascular disease

  • Coronary heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • other cerebrovascular diseases
  • hyperlipidemia
  • primary hypercholesterolemia
  • mixed dyslipidemia
  • primary abetalipoproteinemia
  • hypertriglyceridemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medication is used to reduce the risk of cardiovascular diseases. It lowers the risk of death due to heart disease, myocardial infarction, stroke, and risks associated with vascular procedures in adult patients with a history of coronary heart disease, diabetes, peripheral vascular disease, or stroke. It also helps lower blood lipid levels such as total cholesterol, LDL-cholesterol, and triglycerides while increasing HDL-cholesterol in patients with hyperlipidemia. For patients with familial hypercholesterolemia or dyslipidemia, it can be used alone or in combination with other treatments to manage blood lipids. In young pediatric patients with a family history or those in high-risk groups, it is used as an adjunct to a dietary regimen to lower cholesterol levels. Thus, this medication is effectively used for reducing the risk of cardiovascular diseases and improving hyperlipidemia.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medication. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medication once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medication. A dose of 5 ~ 40 mg of this medication once daily in the evening is recommended. Adjust the dose appropriately according to the initial LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the medication. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if cholesterol levels fall below the target level. Due to the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this medication, particularly during the first year of treatment, should be limited to patients who have taken 80 mg of this medication for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) See below for recommended doses in patients taking this medication concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on results from controlled clinical trials, patients with homozygous familial hypercholesterolemia should take 40 mg of this medication once daily in the evening. Administer this medication in combination with other lipid-lowering treatments (e.g., LDL apheresis), or if other lipid-lowering treatments are not available. (2) In elderly patients, the maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this medication. (3) Use in patients taking verapamil, diltiazem, or dronedarone When this medication is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medication should not exceed 10 mg daily. (4) Use in patients taking amiodarone, amlodipine, or ranolazine When this medication is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medication should not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering agents This medication is effective when used alone or in combination with a bile acid sequestrant. When this medication is coadministered with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medication should not exceed 10 mg daily. (6) Use in patients with renal impairment Because this medication is not extensively excreted by the kidneys, no dose adjustment is needed in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg daily and monitor carefully.

Child dose

10 ~ 17 years: The recommended initial dose is 10 mg of this medication once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Precautions

This medication carries a risk of causing myopathy and rhabdomyolysis that may affect the muscles. This risk can increase, especially when taken at high doses or in conjunction with certain medications. This medication should not be used in patients who are allergic to its ingredients, have severely impaired liver function, are pregnant, breastfeeding women, or those taking certain potent medications. Patients with impaired liver or kidney function, hypothyroidism, or severe myasthenia gravis should use this medication cautiously, and precautions are necessary for elderly patients and women. While taking this medication, any symptoms such as muscle pain, weakness, or tenderness should be reported to a healthcare professional immediately, and if severe unusual symptoms occur, medication should be discontinued. Due to the possibility of liver function abnormalities, it is important to have regular liver function tests. If symptoms of hepatitis, jaundice, etc., occur, treatment should be stopped immediately. This medication can interact with several drugs, so inform your healthcare provider if you are taking other medications, especially when combined with certain antifungals, antibiotics, immunosuppressants, or calcium channel blockers. It should be avoided during pregnancy, and women of childbearing potential should ensure adequate contraception during treatment. If breastfeeding, this medication should not be taken. For pediatric patients, it should be used restrictively for those over 10 years, particularly between the ages of 10 and 17, monitoring its impact on growth and maturation is essential. Elderly patients may be more sensitive to the effects and side effects of this medication, necessitating dose adjustment and careful monitoring. In case of overdose, standard emergency first aid should be performed, as there is no specific antidote, following the instructions of healthcare professionals is crucial. Store this medication out of reach of children in its original container; transferring to another container might lead to quality degradation or misuse.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 89 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • taste disorder
  • extraocular muscle dysfunction
  • facial paresis
  • tremor
  • sensory disturbance
  • peripheral neuropathy
  • peripheral nerve palsy
  • mental disorder
  • anxiety
  • sleep disturbance
  • nightmares
  • depression
  • cognitive impairment
  • myasthenia gravis
  • oculomotor myasthenia
  • hepatitis
  • liver dysfunction
  • jaundice
  • pancreatitis
  • liver failure
  • cholestatic jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • appetite loss
  • vomiting
  • alopecia
  • itching
  • skin changes
  • lichenoid drug rash
  • gynecomastia
  • decreased libido
  • erectile dysfunction
  • cataract progression
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GTP
  • increased bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus erythematosus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • phototoxicity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • erythema multiforme
  • limb sensory numbness
  • paresthesia
  • cold sensation
  • sensory impairment
  • muscle weakness
  • thrombocytopenia
  • interstitial lung disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from getting in, and it should be kept at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain its effectiveness and prevent deterioration.

Appearance and packaging

Appearance

Yellowish brown oval film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.